100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025
Oncology This Week: OncoDaily Weekly Nov 17–23
Bezuclastinib Achieves Positive PEAK Phase 3 Results in Advanced GIST: A Potential New Standard for KIT Exon 17/18 Mutant Disease
FDA Approves Pembrolizumab + Enfortumab Vedotin-ejfv for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Geriatric Oncology at SIOG 2025: From Research to Real-World Care
27 Posts Not to Miss from SIOG 2025
Gevorg Tamamyan: To truly understand global health in times of war, Richard is the person to learn from
Registration is Open for the 7th European Cancer Forum - MSD Europe
